Slide 1FDA/Industry Workshop September, 19, 2003 Johnson & Johnson Pharmaceutical Research and Development L.L.C. 1 Uses and Abuses of (Adaptive) Randomization: An Industry…
Slide 1COMPUTER INTENSIVE AND RE-RANDOMIZATION TESTS IN CLINICAL TRIALS Thomas Hammerstrom, Ph.D. USFDA, Division of Biometrics The opinions expressed are those of the author…
Slide 1Girls’ scholarship program Slide 2 Often small/no impacts on actual learning in education research ◦ Inputs (textbooks, flipcharts) little impact on learning…
Slide 1SESSION 2 Mediation and moderation of treatment effects Andrew Pickles Methods of explanatory analysis for psychological treatment trials workshop Methodology Research…
Slide 1Grandparenting and health in Europe: a longitudinal analysis Di Gessa G, Glaser K and Tinker A Institute of Gerontology, Department of Social Science, Health &…
Slide 1 1 Variable Selection for Tailoring Treatment L. Gunter, J. Zhu & S.A. Murphy ASA, Nov 11, 2008 Slide 2 2 Outline Motivation Need for Variable Selection Characteristics…
Slide 1 Variable Selection for Optimal Decision Making Susan Murphy & Lacey Gunter University of Michigan Statistics Department Artificial Intelligence Seminar Joint…
Slide 1 1 Variable Selection for Tailoring Treatment S.A. Murphy, L. Gunter & J. Zhu May 29, 2008 Slide 2 2 Outline Motivation Need for Variable Selection Characteristics…
Slide 1 Eight Week Randomized Trial of Treatment with Pa-824, Moxifloxacin, and Pyrazinamide in Drug Sensitive and Multi-Drug Resistant Tuberculosis July 21, 2014 20 th International…